Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.35 USD 1.82%
Market Cap: 515.4m USD
Have any thoughts about
Mereo Biopharma Group PLC?
Write Note

Intrinsic Value

MREO latest financial reports are more than 2 years old.
MREO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MREO stock under the Base Case scenario is 2.23 USD. Compared to the current market price of 3.35 USD, Mereo Biopharma Group PLC is Overvalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MREO Intrinsic Value
2.23 USD
Overvaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Mereo Biopharma Group PLC

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MREO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MREO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about MREO?
Bearish
Neutral
Bullish

Fundamental Analysis

3.35 USD
+1.82%
+1.82%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Mereo Biopharma Group PLC
UK
Biotechnology
Market Cap
515.4m USD
IPO
Jun 9, 2016
Employees
49
United Kingdom
Market Cap
515.4m USD
Industry
Biotechnology
IPO
Jun 9, 2016
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Mereo Biopharma Group PLC

Provide an overview of the primary business activities
of Mereo Biopharma Group PLC.

What unique competitive advantages
does Mereo Biopharma Group PLC hold over its rivals?

What risks and challenges
does Mereo Biopharma Group PLC face in the near future?

Has there been any significant insider trading activity
in Mereo Biopharma Group PLC recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mereo Biopharma Group PLC.

Provide P/S
for Mereo Biopharma Group PLC.

Provide P/E
for Mereo Biopharma Group PLC.

Provide P/OCF
for Mereo Biopharma Group PLC.

Provide P/FCFE
for Mereo Biopharma Group PLC.

Provide P/B
for Mereo Biopharma Group PLC.

Provide EV/S
for Mereo Biopharma Group PLC.

Provide EV/GP
for Mereo Biopharma Group PLC.

Provide EV/EBITDA
for Mereo Biopharma Group PLC.

Provide EV/EBIT
for Mereo Biopharma Group PLC.

Provide EV/OCF
for Mereo Biopharma Group PLC.

Provide EV/FCFF
for Mereo Biopharma Group PLC.

Provide EV/IC
for Mereo Biopharma Group PLC.

Show me price targets
for Mereo Biopharma Group PLC made by professional analysts.

What are the Revenue projections
for Mereo Biopharma Group PLC?

How accurate were the past Revenue estimates
for Mereo Biopharma Group PLC?

What are the Net Income projections
for Mereo Biopharma Group PLC?

How accurate were the past Net Income estimates
for Mereo Biopharma Group PLC?

What are the EPS projections
for Mereo Biopharma Group PLC?

How accurate were the past EPS estimates
for Mereo Biopharma Group PLC?

What are the EBIT projections
for Mereo Biopharma Group PLC?

How accurate were the past EBIT estimates
for Mereo Biopharma Group PLC?

Compare the revenue forecasts
for Mereo Biopharma Group PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mereo Biopharma Group PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mereo Biopharma Group PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mereo Biopharma Group PLC compared to its peers.

Compare the P/E ratios
of Mereo Biopharma Group PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Mereo Biopharma Group PLC with its peers.

Analyze the financial leverage
of Mereo Biopharma Group PLC compared to its main competitors.

Show all profitability ratios
for Mereo Biopharma Group PLC.

Provide ROE
for Mereo Biopharma Group PLC.

Provide ROA
for Mereo Biopharma Group PLC.

Provide ROIC
for Mereo Biopharma Group PLC.

Provide ROCE
for Mereo Biopharma Group PLC.

Provide Gross Margin
for Mereo Biopharma Group PLC.

Provide Operating Margin
for Mereo Biopharma Group PLC.

Provide Net Margin
for Mereo Biopharma Group PLC.

Provide FCF Margin
for Mereo Biopharma Group PLC.

Show all solvency ratios
for Mereo Biopharma Group PLC.

Provide D/E Ratio
for Mereo Biopharma Group PLC.

Provide D/A Ratio
for Mereo Biopharma Group PLC.

Provide Interest Coverage Ratio
for Mereo Biopharma Group PLC.

Provide Altman Z-Score Ratio
for Mereo Biopharma Group PLC.

Provide Quick Ratio
for Mereo Biopharma Group PLC.

Provide Current Ratio
for Mereo Biopharma Group PLC.

Provide Cash Ratio
for Mereo Biopharma Group PLC.

What is the historical Revenue growth
over the last 5 years for Mereo Biopharma Group PLC?

What is the historical Net Income growth
over the last 5 years for Mereo Biopharma Group PLC?

What is the current Free Cash Flow
of Mereo Biopharma Group PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mereo Biopharma Group PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mereo Biopharma Group PLC

Current Assets 86.7m
Cash & Short-Term Investments 80.5m
Receivables 1.6m
Other Current Assets 4.6m
Non-Current Assets 2m
PP&E 1.2m
Intangibles 799k
Current Liabilities 14.2m
Accounts Payable 1.7m
Accrued Liabilities 4m
Other Current Liabilities 8.4m
Non-Current Liabilities 2m
Other Non-Current Liabilities 2m
Efficiency

Earnings Waterfall
Mereo Biopharma Group PLC

Revenue
10m GBP
Cost of Revenue
-2.6m GBP
Gross Profit
7.4m GBP
Operating Expenses
-67.9m GBP
Operating Income
-60.5m GBP
Other Expenses
-5.2m GBP
Net Income
-65.7m GBP

Free Cash Flow Analysis
Mereo Biopharma Group PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MREO Profitability Score
Profitability Due Diligence

Mereo Biopharma Group PLC's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Mereo Biopharma Group PLC's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

MREO Solvency Score
Solvency Due Diligence

Mereo Biopharma Group PLC's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
69/100
Solvency
Score

Mereo Biopharma Group PLC's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MREO Price Targets Summary
Mereo Biopharma Group PLC

Wall Street analysts forecast MREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MREO is 7.1 USD with a low forecast of 5.76 USD and a high forecast of 8.4 USD.

Lowest
Price Target
5.76 USD
72% Upside
Average
Price Target
7.1 USD
112% Upside
Highest
Price Target
8.4 USD
151% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MREO?

Click here to dive deeper.

Dividends

Mereo Biopharma Group PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for MREO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MREO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one MREO stock?

The intrinsic value of one MREO stock under the Base Case scenario is 2.23 USD.

Is MREO stock undervalued or overvalued?

Compared to the current market price of 3.35 USD, Mereo Biopharma Group PLC is Overvalued by 33%.

Back to Top